The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Abstract
Although nonclassical estrogen actions initiated at the cell surface have been described in many tissues, the identities of the membrane estrogen receptors (mERs) mediating these actions remain unclear. Here we show that GPR30, an orphan receptor unrelated to nuclear estrogen receptors, has all the binding and signaling characteristics of a mER. A high-affinity (dissociation constant 2.7 nm), limited capacity, displaceable, single binding site specific for estrogens was detected in plasma membranes of SKBR3 breast cancer cells that express GPR30 but lack nuclear estrogen receptors. Progesterone-induced increases and small interfering RNA-induced decreases in GPR30 expression in SKBR3 cells were accompanied by parallel changes in specific estradiol-17beta (E2) binding. Plasma membranes of human embryonic kidney 293 cells transfected with GPR30, but not those of untransfected cells, and human placental tissues that express GPR30 also displayed high-affinity, specific estrogen binding typical of mERs. E2 treatment of transfected cell membranes caused activation of a stimulatory G protein that is directly coupled to the receptor, indicating GPR30 is a G protein-coupled receptor (GPCR), and also increased adenylyl cyclase activity. The finding that the antiestrogens tamoxifen and ICI 182,780, and an environmental estrogen, ortho,para-dichlorodiphenyldichloroethylene (o,p'-DDE), have high binding affinities to the receptor and mimic the actions of E2 has important implications for both the development and treatment of estrogen-dependent breast cancer. GPR30 is structurally unrelated to the recently discovered family of GPCR-like membrane progestin receptors. The identification of a second distinct class of GPCR-like steroid membrane receptors suggests a widespread role for GPCRs in nonclassical steroid hormone actions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
Filardo, E. J. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1649 · Cited by 1,383
Self-citationRazandi, M., Pedram, A., Greene, G. L., & Levin, E. R. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0239 · Cited by 1,040
Multiple Actions of Steroid Hormones—A Focus on Rapid, Nongenomic Effects
Falkenstein, E., Tillmann, H.-C., Christ, M., Feuring, M., & Wehling, M. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01468-6 · Cited by 991
Chen, Z., Yuhanna, I. S., Galcheva-Gargova, Z., Karas, R. H., Mendelsohn, M. E., & Shaul, P. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5347 · Cited by 923
Filardo, E. J., Quinn, J. A., Frackelton, A. R., & Bland, K. I. (2002) · Molecular Endocrinology · doi:10.1210/me.16.1.70 · Cited by 904
Self-citationZhu, Y., Rice, C. D., Pang, Y., Pace, M., & Thomas, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336132100 · Cited by 798
Self-citationZhu, Y., Bond, J., & Thomas, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0436133100 · Cited by 709
Self-citationThornton, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091553298 · Cited by 681
Cited by
Items 101–108 of 108
Estrogenic regulation of social behavior and sexually dimorphic brain formation
Ogawa, S., Tsukahara, S., Choleris, E., & Vasudevan, N. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.012 · Cited by 60
Lv, X., He, C., Huang, C., Hua, G., Wang, Z., Remmenga, S. W., Rodabough, K. J., Karpf, A. R., Dong, J., Davis, J. S., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0626 · Cited by 53
Self-citationEstradiol rapidly modulates odor responses in mouse vomeronasal sensory neurons
Cherian, S., Wai Lam, Y., McDaniels, I., Struziak, M., & Delay, R. J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.011 · Cited by 53
Oestrogen receptors interact with the α-catalytic subunit of AMP-activated protein kinase
Lipovka, Y., Chen, H., Vagner, J., Price, T. J., Tsao, T.-S., & Konhilas, J. P. (2015) · Bioscience Reports · doi:10.1042/bsr20150074 · Cited by 49
The role of G protein-coupled estrogen receptor 1 on neurological disorders
Roque, C., Mendes-Oliveira, J., Duarte-Chendo, C., & Baltazar, G. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100786 · Cited by 41
Duan, H., Ge, W., Yang, S., Lv, J., Ding, Z., Hu, J., Zhang, Y., Zhao, X., Hua, Y., & Xiao, L. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105819 · Cited by 19
Liu, L., Zhou, Y., Liu, J., Zhang, X., He, C., Zeng, X., Dejenie, R., Zeb, U., Zeng, Q., Liu, L., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07005-0 · Cited by 13
High affinity nuclear and nongenomic estradiol binding sites in the human and mouse lens
Kirker, M. R., Gallagher, K. M., Witt-Enderby, P. A., & Davis, V. L. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.04.002 · Cited by 10
Metadata
- Authors
- Thomas, P., Pang, Y., Filardo, E. J., & Dong, J.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-02-01
- Volume
- 146
- Issue
- 2
- Pages
- 624-632
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2122015809
- Cited by
- 1,407
- References
- 45
- FWCI
- 33.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.